Identification of a TSPY co-expression network associated with DNA hypomethylation and tumor gene expression in somatic cancers
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 43 (10) , 577-585
Abstract
No abstract availableKeywords
Funding Information
- Department of Veterans Affairs
- Department of Defense (W81XWH-16-1-0488)
- Department of Veterans Affairs
This publication has 65 references indexed in Scilit:
- TCC: an R package for comparing tag count data with robust normalization strategiesBMC Bioinformatics, 2013
- Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotideCancer Immunology, Immunotherapy, 2012
- Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinomaBritish Journal of Cancer, 2012
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potentialMolecular Oncology, 2011
- Systems Biology and Genomics of Breast CancerCold Spring Harbor Perspectives in Biology, 2010
- WGCNA: an R package for weighted correlation network analysisBMC Bioinformatics, 2008
- The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumorsHuman Pathology, 2007
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancersNature Genetics, 2006
- MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsProceedings of the National Academy of Sciences, 2006
- [9] TM4 Microarray Software Suite2006